Therefore, the downregulation of intact E-cadherin and the production of soluble E-cadherin, mediated by TMEM52B suppression, may contribute to the accelerated malignancy aggressiveness and tumor progression through both autocrine and paracrine mechanisms. Here, TMEM52B is linked to neoplasm.